Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Jefferies Cuts Price Target on Marine Bio (MBII) Following a Light 1Q
May 17, 2016 8:11 AM EDTJefferies maintained a Hold rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $0.75 (from $1.00), following the company's 1Q earnings report. MBII reported a loss of $0.38, $0.13 worse than consensus. Sales rose 30%, with a 79% increase in product shipments.
Analyst Laurence... More



